ID   ARGI1_RAT               Reviewed;         323 AA.
AC   P07824; Q5BK93;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 2.
DT   22-JUL-2015, entry version 156.
DE   RecName: Full=Arginase-1;
DE            EC=3.5.3.1;
DE   AltName: Full=Liver-type arginase;
DE   AltName: Full=Type I arginase;
GN   Name=Arg1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=3571256;
RA   Kawamoto S., Amaya Y., Murakami K., Tokunaga F., Iwanaga S.,
RA   Kobayashi K., Saheki T., Kimura S., Mori M.;
RT   "Complete nucleotide sequence of cDNA and deduced amino acid sequence
RT   of rat liver arginase.";
RL   J. Biol. Chem. 262:6280-6283(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=2892837;
RA   Ohtake A., Takiguchi M., Shigeto Y., Amaya Y., Kawamoto S., Mori M.;
RT   "Structural organization of the gene for rat liver-type arginase.";
RL   J. Biol. Chem. 263:2245-2249(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   MUTAGENESIS OF GLY-235.
RX   PubMed=11883902; DOI=10.1006/abbi.2001.2720;
RA   Lavulo L.T., Emig F.A., Ash D.E.;
RT   "Functional consequences of the G235R mutation in liver arginase
RT   leading to hyperargininemia.";
RL   Arch. Biochem. Biophys. 399:49-55(2002).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS).
RX   PubMed=8849731; DOI=10.1038/383554a0;
RA   Kanyo Z.F., Scolnick L.R., Ash D.E., Christianson D.W.;
RT   "Structure of a unique binuclear manganese cluster in arginase.";
RL   Nature 383:554-557(1996).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=9265637; DOI=10.1021/bi970800v;
RA   Scolnick L.R., Kanyo Z.F., Cavalli R.C., Ash D.E., Christianson D.W.;
RT   "Altering the binuclear manganese cluster of arginase diminishes
RT   thermostability and catalytic function.";
RL   Biochemistry 36:10558-10565(1997).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS).
RX   PubMed=10542097; DOI=10.1038/14929;
RA   Cox J.D., Kim N.N., Traish A.M., Christianson D.W.;
RT   "Arginase-boronic acid complex highlights a physiological role in
RT   erectile function.";
RL   Nat. Struct. Biol. 6:1043-1047(1999).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 6-319 OF MUTANTS ASN-101;
RP   GLU-101; ASN-128; GLU-128; ALA-232; CYS-232 AND GLU-234 IN COMPLEXES
RP   WITH MANGANESE IONS, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF HIS-101; ASP-128; ASP-232 AND ASP-234.
RX   PubMed=12820884; DOI=10.1021/bi030074y;
RA   Cama E., Emig F.A., Ash D.E., Christianson D.W.;
RT   "Structural and functional importance of first-shell metal ligands in
RT   the binuclear manganese cluster of arginase I.";
RL   Biochemistry 42:7748-7758(2003).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 6-319 IN COMPLEX WITH
RP   MANGANESE IONS AND THE SYNTHETIC INHIBITOR (S)-2-AMINO-7-OXOHEPTANOIC
RP   ACID.
RX   PubMed=15315440; DOI=10.1021/ja047788w;
RA   Shin H., Cama E., Christianson D.W.;
RT   "Design of amino acid aldehydes as transition-state analogue
RT   inhibitors of arginase.";
RL   J. Am. Chem. Soc. 126:10278-10284(2004).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 6-319 OF MUTANTS ALA-141;
RP   ASN-141; ASP-141 AND CYS-141 IN COMPLEX WITH MANGANESE IONS, COFACTOR,
RP   MUTAGENESIS OF HIS-141, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16266687; DOI=10.1016/j.abb.2005.09.009;
RA   Colleluori D.M., Reczkowski R.S., Emig F.A., Cama E., Cox J.D.,
RA   Scolnick L.R., Compher K., Jude K., Han S., Viola R.E.,
RA   Christianson D.W., Ash D.E.;
RT   "Probing the role of the hyper-reactive histidine residue of
RT   arginase.";
RL   Arch. Biochem. Biophys. 444:15-26(2005).
CC   -!- CATALYTIC ACTIVITY: L-arginine + H(2)O = L-ornithine + urea.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00742,
CC         ECO:0000269|PubMed:12820884, ECO:0000269|PubMed:16266687};
CC       Note=Binds 2 manganese ions per subunit. {ECO:0000255|PROSITE-
CC       ProRule:PRU00742, ECO:0000269|PubMed:12820884,
CC       ECO:0000269|PubMed:16266687};
CC   -!- ENZYME REGULATION: Inactivated by diethyl pyrocarbonate (DEPC).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.4 mM for arginine {ECO:0000269|PubMed:12820884,
CC         ECO:0000269|PubMed:16266687};
CC   -!- PATHWAY: Nitrogen metabolism; urea cycle; L-ornithine and urea
CC       from L-arginine: step 1/1.
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:15315440,
CC       ECO:0000269|PubMed:16266687}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Detected in liver (at protein level).
CC       {ECO:0000269|PubMed:16266687}.
CC   -!- INDUCTION: By arginine or homoarginine.
CC   -!- SIMILARITY: Belongs to the arginase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00742}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02720; AAA40761.1; -; mRNA.
DR   EMBL; M17931; AAA40760.1; -; Genomic_DNA.
DR   EMBL; M17924; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; M17925; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; M17926; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; M17927; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; M17928; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; M17929; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; M17930; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; BC091158; AAH91158.1; -; mRNA.
DR   PIR; A26702; A26702.
DR   RefSeq; NP_058830.2; NM_017134.3.
DR   UniGene; Rn.9857; -.
DR   PDB; 1D3V; X-ray; 1.70 A; A/B=1-323.
DR   PDB; 1HQ5; X-ray; 2.30 A; A/B=1-323.
DR   PDB; 1HQF; X-ray; 2.90 A; A/B/C=1-323.
DR   PDB; 1HQG; X-ray; 2.00 A; A/B/C=1-323.
DR   PDB; 1HQH; X-ray; 2.80 A; A/B/C=1-323.
DR   PDB; 1HQX; X-ray; 3.00 A; A/B/C=1-323.
DR   PDB; 1P8M; X-ray; 2.84 A; A/B/C=6-319.
DR   PDB; 1P8N; X-ray; 2.90 A; A/B/C=6-319.
DR   PDB; 1P8O; X-ray; 2.96 A; A/B/C=6-319.
DR   PDB; 1P8P; X-ray; 2.50 A; A/B/C=6-319.
DR   PDB; 1P8Q; X-ray; 2.95 A; A/B/C=6-319.
DR   PDB; 1P8R; X-ray; 2.50 A; A/B=6-313.
DR   PDB; 1P8S; X-ray; 3.20 A; A/B/C=6-319.
DR   PDB; 1R1O; X-ray; 2.80 A; A/B/C=1-323.
DR   PDB; 1RLA; X-ray; 2.10 A; A/B/C=1-323.
DR   PDB; 1T4P; X-ray; 2.60 A; A/B/C=6-319.
DR   PDB; 1T4R; X-ray; 2.60 A; A/B/C=6-319.
DR   PDB; 1T4S; X-ray; 2.80 A; A/B/C=6-319.
DR   PDB; 1T4T; X-ray; 2.20 A; A/B/C=6-319.
DR   PDB; 1T5F; X-ray; 2.20 A; A/B/C=6-319.
DR   PDB; 1T5G; X-ray; 2.40 A; A/B/C=6-319.
DR   PDB; 1TA1; X-ray; 2.50 A; A/B/C=6-319.
DR   PDB; 1TBH; X-ray; 2.70 A; A/B/C=6-319.
DR   PDB; 1TBJ; X-ray; 2.80 A; A/B/C=6-319.
DR   PDB; 1TBL; X-ray; 3.10 A; A/B/C=6-319.
DR   PDB; 1ZPE; X-ray; 1.70 A; A/B/C=6-319.
DR   PDB; 1ZPG; X-ray; 1.90 A; A/B/C=6-319.
DR   PDB; 2RLA; X-ray; 3.00 A; A/B/C=1-323.
DR   PDB; 3E8Q; X-ray; 2.90 A; A/B/C=1-323.
DR   PDB; 3E8Z; X-ray; 2.00 A; A/B/C=1-323.
DR   PDB; 3E9B; X-ray; 2.15 A; A/B/C=1-323.
DR   PDB; 3RLA; X-ray; 2.54 A; A/B/C=1-323.
DR   PDB; 4RLA; X-ray; 2.94 A; A/B/C=1-323.
DR   PDB; 5RLA; X-ray; 2.74 A; A/B/C=1-323.
DR   PDBsum; 1D3V; -.
DR   PDBsum; 1HQ5; -.
DR   PDBsum; 1HQF; -.
DR   PDBsum; 1HQG; -.
DR   PDBsum; 1HQH; -.
DR   PDBsum; 1HQX; -.
DR   PDBsum; 1P8M; -.
DR   PDBsum; 1P8N; -.
DR   PDBsum; 1P8O; -.
DR   PDBsum; 1P8P; -.
DR   PDBsum; 1P8Q; -.
DR   PDBsum; 1P8R; -.
DR   PDBsum; 1P8S; -.
DR   PDBsum; 1R1O; -.
DR   PDBsum; 1RLA; -.
DR   PDBsum; 1T4P; -.
DR   PDBsum; 1T4R; -.
DR   PDBsum; 1T4S; -.
DR   PDBsum; 1T4T; -.
DR   PDBsum; 1T5F; -.
DR   PDBsum; 1T5G; -.
DR   PDBsum; 1TA1; -.
DR   PDBsum; 1TBH; -.
DR   PDBsum; 1TBJ; -.
DR   PDBsum; 1TBL; -.
DR   PDBsum; 1ZPE; -.
DR   PDBsum; 1ZPG; -.
DR   PDBsum; 2RLA; -.
DR   PDBsum; 3E8Q; -.
DR   PDBsum; 3E8Z; -.
DR   PDBsum; 3E9B; -.
DR   PDBsum; 3RLA; -.
DR   PDBsum; 4RLA; -.
DR   PDBsum; 5RLA; -.
DR   ProteinModelPortal; P07824; -.
DR   SMR; P07824; 6-319.
DR   BioGrid; 247899; 2.
DR   IntAct; P07824; 1.
DR   MINT; MINT-4567374; -.
DR   STRING; 10116.ENSRNOP00000017911; -.
DR   ChEMBL; CHEMBL3232699; -.
DR   PhosphoSite; P07824; -.
DR   PaxDb; P07824; -.
DR   PRIDE; P07824; -.
DR   Ensembl; ENSRNOT00000017911; ENSRNOP00000017911; ENSRNOG00000013304.
DR   GeneID; 29221; -.
DR   KEGG; rno:29221; -.
DR   CTD; 383; -.
DR   RGD; 2150; Arg1.
DR   eggNOG; COG0010; -.
DR   GeneTree; ENSGT00530000063082; -.
DR   HOGENOM; HOG000204319; -.
DR   HOVERGEN; HBG003030; -.
DR   InParanoid; P07824; -.
DR   KO; K01476; -.
DR   OMA; EQECDVK; -.
DR   OrthoDB; EOG747PJ5; -.
DR   PhylomeDB; P07824; -.
DR   TreeFam; TF300034; -.
DR   BRENDA; 3.5.3.1; 5301.
DR   Reactome; REACT_328693; Urea cycle.
DR   SABIO-RK; P07824; -.
DR   UniPathway; UPA00158; UER00270.
DR   EvolutionaryTrace; P07824; -.
DR   NextBio; 608419; -.
DR   PRO; PR:P07824; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Genevisible; P07824; RN.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0004053; F:arginase activity; IDA:RGD.
DR   GO; GO:0030145; F:manganese ion binding; IDA:RGD.
DR   GO; GO:0007568; P:aging; IEP:RGD.
DR   GO; GO:0019547; P:arginine catabolic process to ornithine; IDA:RGD.
DR   GO; GO:0006525; P:arginine metabolic process; IDA:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:RGD.
DR   GO; GO:0032964; P:collagen biosynthetic process; IMP:RGD.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0030324; P:lung development; IEP:RGD.
DR   GO; GO:0060056; P:mammary gland involution; IEP:RGD.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEP:RGD.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:RGD.
DR   GO; GO:0070207; P:protein homotrimerization; IDA:RGD.
DR   GO; GO:0010963; P:regulation of L-arginine import; IDA:RGD.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0043200; P:response to amino acid; IEP:RGD.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0046686; P:response to cadmium ion; IEP:RGD.
DR   GO; GO:0042493; P:response to drug; IEP:RGD.
DR   GO; GO:0009635; P:response to herbicide; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0010042; P:response to manganese ion; IEP:RGD.
DR   GO; GO:0051597; P:response to methylmercury; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0010269; P:response to selenium ion; IEP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0033189; P:response to vitamin A; IEP:RGD.
DR   GO; GO:0033197; P:response to vitamin E; IEP:RGD.
DR   GO; GO:0009611; P:response to wounding; IEP:RGD.
DR   GO; GO:0010043; P:response to zinc ion; IEP:RGD.
DR   GO; GO:0000050; P:urea cycle; IDA:RGD.
DR   Gene3D; 3.40.800.10; -; 1.
DR   InterPro; IPR014033; Arginase.
DR   InterPro; IPR006035; Ureohydrolase.
DR   InterPro; IPR023696; Ureohydrolase_domain.
DR   InterPro; IPR020855; Ureohydrolase_Mn_BS.
DR   PANTHER; PTHR11358; PTHR11358; 1.
DR   Pfam; PF00491; Arginase; 1.
DR   PIRSF; PIRSF036979; Arginase; 1.
DR   PRINTS; PR00116; ARGINASE.
DR   TIGRFAMs; TIGR01229; rocF_arginase; 1.
DR   PROSITE; PS01053; ARGINASE_1; 1.
DR   PROSITE; PS51409; ARGINASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Arginine metabolism; Complete proteome; Cytoplasm;
KW   Hydrolase; Manganese; Metal-binding; Phosphoprotein;
KW   Reference proteome; Urea cycle.
FT   CHAIN         1    323       Arginase-1.
FT                                /FTId=PRO_0000173697.
FT   REGION      126    130       Substrate binding.
FT   REGION      137    139       Substrate binding.
FT   METAL       101    101       Manganese 1.
FT   METAL       124    124       Manganese 1.
FT   METAL       124    124       Manganese 2.
FT   METAL       126    126       Manganese 2.
FT   METAL       128    128       Manganese 1.
FT   METAL       232    232       Manganese 1.
FT   METAL       232    232       Manganese 2.
FT   METAL       234    234       Manganese 2.
FT   BINDING     183    183       Substrate.
FT   MOD_RES      17     17       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q61176}.
FT   MOD_RES      62     62       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P05089}.
FT   MOD_RES      72     72       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61176}.
FT   MOD_RES      75     75       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q61176}.
FT   MOD_RES     163    163       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P05089}.
FT   MOD_RES     217    217       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P05089}.
FT   MOD_RES     281    281       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q61176}.
FT   MUTAGEN     101    101       H->E: Reduced catalytic activity. No
FT                                effect on manganese binding.
FT                                {ECO:0000269|PubMed:12820884}.
FT   MUTAGEN     128    128       D->E,N: Reduced manganese binding and
FT                                strongly reduced catalytic activity.
FT                                {ECO:0000269|PubMed:12820884}.
FT   MUTAGEN     141    141       H->A,C,D: Strongly reduced catalytic
FT                                activity. Minor effect on affinity for
FT                                arginine. {ECO:0000269|PubMed:16266687}.
FT   MUTAGEN     141    141       H->N: Reduced affinity for arginine and
FT                                reduced catalytic activity.
FT                                {ECO:0000269|PubMed:16266687}.
FT   MUTAGEN     232    232       D->A: Loss of one manganese ion and
FT                                strongly reduced catalytic activity.
FT                                {ECO:0000269|PubMed:12820884}.
FT   MUTAGEN     232    232       D->C: Reduced manganese binding and
FT                                strongly reduced catalytic activity.
FT                                {ECO:0000269|PubMed:12820884}.
FT   MUTAGEN     234    234       D->A,E,H: Reduced manganese binding and
FT                                strongly reduced catalytic activity.
FT                                {ECO:0000269|PubMed:12820884}.
FT   MUTAGEN     235    235       G->A: 56% of wild-type activity.
FT                                {ECO:0000269|PubMed:11883902}.
FT   MUTAGEN     235    235       G->R: Loss of manganese-binding and
FT                                activity. {ECO:0000269|PubMed:11883902}.
FT   CONFLICT    298    298       A -> P (in Ref. 1; AAA40761/AAA40760).
FT                                {ECO:0000305}.
FT   STRAND        8     12       {ECO:0000244|PDB:1D3V}.
FT   STRAND       19     21       {ECO:0000244|PDB:1ZPE}.
FT   HELIX        22     26       {ECO:0000244|PDB:1D3V}.
FT   HELIX        27     33       {ECO:0000244|PDB:1D3V}.
FT   HELIX        36     40       {ECO:0000244|PDB:1D3V}.
FT   STRAND       43     45       {ECO:0000244|PDB:1D3V}.
FT   STRAND       47     52       {ECO:0000244|PDB:1D3V}.
FT   STRAND       64     66       {ECO:0000244|PDB:5RLA}.
FT   STRAND       67     69       {ECO:0000244|PDB:1ZPE}.
FT   HELIX        70     89       {ECO:0000244|PDB:1D3V}.
FT   STRAND       93     97       {ECO:0000244|PDB:1D3V}.
FT   HELIX       101    103       {ECO:0000244|PDB:1D3V}.
FT   HELIX       104    114       {ECO:0000244|PDB:1D3V}.
FT   STRAND      119    126       {ECO:0000244|PDB:1D3V}.
FT   TURN        132    134       {ECO:0000244|PDB:1D3V}.
FT   STRAND      136    138       {ECO:0000244|PDB:1TBH}.
FT   HELIX       140    142       {ECO:0000244|PDB:1D3V}.
FT   HELIX       144    148       {ECO:0000244|PDB:1D3V}.
FT   HELIX       150    152       {ECO:0000244|PDB:1D3V}.
FT   STRAND      153    156       {ECO:0000244|PDB:1P8O}.
FT   TURN        160    164       {ECO:0000244|PDB:1HQH}.
FT   HELIX       171    173       {ECO:0000244|PDB:1D3V}.
FT   STRAND      174    179       {ECO:0000244|PDB:1D3V}.
FT   HELIX       184    193       {ECO:0000244|PDB:1D3V}.
FT   STRAND      196    199       {ECO:0000244|PDB:1D3V}.
FT   HELIX       200    206       {ECO:0000244|PDB:1D3V}.
FT   HELIX       208    220       {ECO:0000244|PDB:1D3V}.
FT   STRAND      221    223       {ECO:0000244|PDB:3E9B}.
FT   STRAND      227    232       {ECO:0000244|PDB:1D3V}.
FT   HELIX       233    235       {ECO:0000244|PDB:1D3V}.
FT   TURN        238    240       {ECO:0000244|PDB:1D3V}.
FT   STRAND      244    246       {ECO:0000244|PDB:1D3V}.
FT   HELIX       254    267       {ECO:0000244|PDB:1D3V}.
FT   STRAND      270    276       {ECO:0000244|PDB:1D3V}.
FT   HELIX       280    282       {ECO:0000244|PDB:1ZPE}.
FT   STRAND      283    285       {ECO:0000244|PDB:1P8R}.
FT   HELIX       286    303       {ECO:0000244|PDB:1D3V}.
SQ   SEQUENCE   323 AA;  34973 MW;  5A92CB0931F9A053 CRC64;
     MSSKPKPIEI IGAPFSKGQP RGGVEKGPAA LRKAGLVEKL KETEYNVRDH GDLAFVDVPN
     DSPFQIVKNP RSVGKANEQL AAVVAETQKN GTISVVLGGD HSMAIGSISG HARVHPDLCV
     IWVDAHTDIN TPLTTSSGNL HGQPVAFLLK ELKGKFPDVP GFSWVTPCIS AKDIVYIGLR
     DVDPGEHYII KTLGIKYFSM TEVDKLGIGK VMEETFSYLL GRKKRPIHLS FDVDGLDPVF
     TPATGTPVVG GLSYREGLYI TEEIYKTGLL SGLDIMEVNP TLGKTPEEVT RTVNTAVALT
     LSCFGTKREG NHKPETDYLK PPK
//
